Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07564440 (Clinical and Biological Safety Study of the BTT Hyperthermia in Adult Subjects), which is not on this map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT07564440 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation
Clinical and Biological Safety Study of the BTT Hyperthermia in Adult Subjects
TypeinterventionalSponsorMarc AbreuRan2026 to 2026Enrolled20ConditionsSafety StudyArmsHyperthermia
3 · Its place in the literature
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Anna Lena HohneckDepartment of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Heidelberg, Germany.ORCID 0000-0002-7629-2770
Vivien Schmitz-SolheidDepartment of Haematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Deniz GencerKlinik Oeschelbronn, Center of Integrative Oncology, Pain Management and Palliative Medicine, 75223 Oeschelbronn, Germany.
Maik SchroederKlinik Oeschelbronn, Center of Integrative Oncology, Pain Management and Palliative Medicine, 75223 Oeschelbronn, Germany.
Hartmut RiessAnthroMed Öschelbronn, Centrum für Integrative Medizin, 75223 Oeschelbronn, Germany.
Annette GerhardsAnthroMed Öschelbronn, Centrum für Integrative Medizin, 75223 Oeschelbronn, Germany.
Iris BurkholderDepartment of Health Sciences, Fulda University of Applied Sciences, 36037 Fulda, Germany.ORCID 0000-0001-6862-7262
Stefan Heckel-ReusserHeckel Medizintechnik GmbH, 73728 Esslingen, Germany.
Julia GottfriedStuttgart Cancer Center (SCC)-Tumorzentrum Eva Mayr-Stihl, Zentrum für Integrative Tumormedizin, 70174 Stuttgart, Germany.
Ralf-Dieter HofheinzDepartment of Haematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0001-5972-8504
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Predictors of Successful Whole-Body Hyperthermia in Cancer Patients: Target Temperature Achievement and Safety Analysis. · full record | OpenQuestion